Altamira Therapeutics Ltd... (CYTO)
NASDAQ: CYTO
· Real-Time Price · USD
0.30
0.00 (0.00%)
At close: Jan 16, 2025, 10:00 PM
Altamira Therapeutics Cash Flow Statement
Financials in CHF. Fiscal
year is
January - December.
| Fiscal Year | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 | Q1 2021 |
| Period Ending | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 |
Net Income | -2.71M | -2.71M | -8.68M | -9.61M | -4.12M | -4.12M | -5.15M | -5.15M | -3.38M | -3.38M |
Depreciation & Amortization | 29.83K | 29.83K | 29.72K | 29.72K | 29.72K | 29.72K | 26.36K | 26.36K | 11.82K | 11.82K |
Stock-Based Compensation | 90.64K | 90.64K | n/a | 82.61K | 90.4K | 90.4K | -287.09K | 89.39K | 522.46K | 522.46K |
Other Working Capital | 3.14M | -45.67K | 139.96K | 139.97K | 646.32K | 646.32K | -795.27K | -795.27K | 6.12K | 6.12K |
Other Non-Cash Items | -1.06M | -1.06M | 6.89M | 7.74M | 202.85K | 202.85K | 1.87M | 1.78M | 505.54K | 505.54K |
Deferred Income Tax | n/a | n/a | n/a | n/a | n/a | n/a | -170.9K | n/a | n/a | n/a |
Change in Working Capital | -206.52K | -206.52K | 207.32K | 207.33K | 1M | 1M | -1.12M | -1.12M | -121.81K | -121.81K |
Operating Cash Flow | -3.86M | -3.86M | -1.55M | -1.55M | -2.79M | -2.79M | -4.38M | -4.38M | -2.46M | -2.46M |
Capital Expenditures | n/a | n/a | n/a | n/a | n/a | n/a | 1.87M | n/a | n/a | n/a |
Cash Acquisitions | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Purchase of Investments | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Sales Maturities Of Investments | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Other Investing Acitivies | 120.00 | 120.00 | -304.13K | -304.13K | -766.78K | -766.78K | -758.08K | -758.07K | -994.45K | -994.45K |
Investing Cash Flow | 120.00 | 120.00 | -304.13K | -304.13K | -766.78K | -766.78K | -758.08K | -758.07K | -994.45K | -994.45K |
Debt Repayment | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Common Stock Repurchased | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Dividend Paid | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Other Financial Acitivies | 3.85M | 3.85M | 1.65M | 1.65M | 3.27M | 3.27M | 1.38M | 1.38M | 1.92M | 1.92M |
Financial Cash Flow | 3.85M | 3.85M | 1.65M | 1.65M | 3.27M | 3.27M | 1.38M | 1.38M | 1.92M | 1.92M |
Net Cash Flow | n/a | 17.09K | -178.63K | -178.63K | -305.77K | -305.77K | -4.41M | -3.74M | -1.4M | -1.4M |
Free Cash Flow | -3.86M | -3.86M | -1.55M | -1.55M | -2.79M | -2.79M | -2.51M | -4.38M | -2.46M | -2.46M |